Are material releases being delayed while your testing laboratory completes investigations?
Laboratory reporting times play a crucial role in the timely approval of incoming goods and t...
With the latest in LCMS technology, Chemika has commenced testing of pharmaceutical materials for nitrosamines. Methods have been established for a number of critical small molecule nitrosamines and we have the capability to test for ingredient...
Effective from the 3rd of November, Stephanie LeStrange has been promoted to the position of Laboratory Services Manager replacing Richard Miller in the role.
For the past few years, Stephanie has been employed in the role of Laboratory Operations ...
Chemika has been a proud sponsor of St Kilda Cycling Club over the past three years and have recently extended their sponsorship until 2027.
St Kilda Cycling Club has celebrated GOLD at the recent Olymp...
This year, our esteemed Analytical Development Manager Andrew Jones, celebrated an impressive milestone of 15 years of dedicated service with Chemika.
Chemika was Andrew’s first employer following com...
As part of the progressive digitisation of our quality system, validation and investigation reports will be integrated into our eQMS with analytical signatures replaced by electronic signatures.
The rep...
Chemika is proud to be a sponsor at the 2024 PharmOut Pharma and Device Forum.
Our Managing Director and Chief Chemist, Alan Doughty, Quality Manager, Catherine Micallef, Laboratory Operations Leader, S...
Stability testing of new medical products or products in early stage clinical trial is one of the services offered by Chemika. Shelf life studies are complemented by method development and validation which allow our customers to register medicines or comm...
As a way of streamlining QA processes and keeping increasingly complex systems manageable, Chemika has implemented an electronic quality management system (eQMS).
Following vendor selection in 2022 impl...
In late April Chemika was the subject of an FDA audit of our operation. We have been registered as a facility with the FDA since November 2021, and this is the first time the FDA have travelled to audit us. Over the course of 3 days the auditor identified...